Evidence map›Paper›PMID 28717077›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.

Shuichi Miyamoto, Mototsugu Kato, Kana Matsuda, Satoshi Abiko, Momoko Tsuda, Takeshi Mizushima, Keiko Yamamoto, Shoko Ono, Takahiko Kudo, Yuichi Shimizu and 3 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Gastritis, Gastric Polyps and Gastric Cancer.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Gastric hyperplastic polyps inversely associated with currentExperimental and therapeutic medicine · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Shuichi MiyamotoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Mototsugu KatoNational Hospital Organization Hakodate Hospital, Japan.
Kana MatsudaDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Satoshi AbikoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Momoko TsudaDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Takeshi MizushimaDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Keiko YamamotoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Shoko OnoDivision of Endoscopy, Hokkaido University Hospital, Japan.
Takahiko KudoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Yuichi ShimizuDivision of Endoscopy, Hokkaido University Hospital, Japan.
Kanako C HatanakaDepartment of Surgical Pathology, Hokkaido University Hospital, Japan.
Izumi TsunematsuDepartment of Internal Medicine, Toei Hospital, Japan.
Naoya SakamotoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan.
Hokkaido University · JPHokkaido University Hospital · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year-old man with gastroesophageal reflux disease (GERD) was referred to our hospital. Esophagogastroduodenoscopy (EGD) revealed no evidence of any polypoid lesions in the stomach, and the patient had no history of Helicobacter pylori infection. He received omeprazole (20 mg) once daily for the GERD. EGD was performed at 1 year after the start of omeprazole administration, and this time, gastric hyperplastic polyps (GHPs) were detected. The GHPs increased in size as the omeprazole treatment continued, but they markedly decreased in size following omeprazole discontinuation. Thus, the administration of proton pump inhibitors may be a risk factor for the development of GHP independent of H. pylori infection.

Indexed as

Adenomatous PolypsGastroesophageal RefluxHelicobacter InfectionsHelicobacter pyloriHumansMaleMiddle AgedOmeprazoleProton Pump InhibitorsStomach NeoplasmsTreatment OutcomeOmeprazoleProton Pump Inhibitorsgastric hyperplastic polypgastringastrin receptorHelicobacter pyloriproton pump inhibitor

Identifiers

PMID28717077
PMCPMC5548674
OpenAlexW2735360688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.